CommentsComments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments. We have migrated to a new commenting platform. If you are already a registered user of The Hindu and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.
Natco Pharma’s Vizag FDF unit gets 4 U.S. FDA observations
Natco Pharma's Vizag FDF unit receives four FDA observations, but remains confident in addressing them promptly.








